Treatment can involve targeted medications or careful monitoring. Myeloproliferative disorders are a group of cancers involving the uncontrolled replication of cells derived from myeloid stem cells.

Myeloproliferative disorders include several different conditions that are characterized by excess production of blood cells ...

Veliparib ER is under clinical development by AbbVie and currently in Phase II for Myeloproliferative Disorders.

One research noted the persistent efforts to develop new treatments for myeloproliferative neoplasms (MPNs), a commitment ...

Managing a younger person with a myeloproliferative neoplasm (MPN) includes a lot of long-term considerations, including ...

The measurable residual disease (MRD ... including acute myeloid leukemia (AML), myelodysplastic syndromes and myeloproliferative neoplasms. The trial was led by Courtney DiNardo, M.D., professor ...